Skip to main content
. 2020 Feb 22;12(2):189. doi: 10.3390/pharmaceutics12020189

Figure 1.

Figure 1

Preparation and scheme-illustrated components of (A) sphingomyelin-based nanosystems (SNs)-stearylamine (ST) and (B) SNs-Lipid complexes (Lpx).